These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 16143730)

  • 1. Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function.
    Krystal JH; Perry EB; Gueorguieva R; Belger A; Madonick SH; Abi-Dargham A; Cooper TB; Macdougall L; Abi-Saab W; D'Souza DC
    Arch Gen Psychiatry; 2005 Sep; 62(9):985-94. PubMed ID: 16143730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
    Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L
    Encephale; 2001; 27(1):53-9. PubMed ID: 11294039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
    Krystal JH; Karper LP; Seibyl JP; Freeman GK; Delaney R; Bremner JD; Heninger GR; Bowers MB; Charney DS
    Arch Gen Psychiatry; 1994 Mar; 51(3):199-214. PubMed ID: 8122957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.
    Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Obradovic M; Kovar KA
    Pharmacopsychiatry; 2005 Nov; 38(6):301-11. PubMed ID: 16342002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia.
    D'Souza DC; Ahn K; Bhakta S; Elander J; Singh N; Nadim H; Jatlow P; Suckow RF; Pittman B; Ranganathan M
    Biol Psychiatry; 2012 Nov; 72(9):785-94. PubMed ID: 22717030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of significant interactive effects of high-dose D-cycloserine and ethanol in healthy human subjects: preliminary insights into ethanol actions at the glycine B site of NMDA glutamate receptors.
    Trevisan L; Petrakis IL; Pittman B; Gueorguieva R; D'Souza DC; Perry E; Limoncelli D; Krystal JH
    Alcohol Clin Exp Res; 2008 Jan; 32(1):36-42. PubMed ID: 18028532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
    Javitt DC
    Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.
    Kegeles LS; Abi-Dargham A; Zea-Ponce Y; Rodenhiser-Hill J; Mann JJ; Van Heertum RL; Cooper TB; Carlsson A; Laruelle M
    Biol Psychiatry; 2000 Oct; 48(7):627-40. PubMed ID: 11032974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.
    Malhotra AK; Pinals DA; Weingartner H; Sirocco K; Missar CD; Pickar D; Breier A
    Neuropsychopharmacology; 1996 May; 14(5):301-7. PubMed ID: 8703299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine effects on CNS responses assessed with MEG/EEG in a passive auditory sensory-gating paradigm: an attempt for modelling some symptoms of psychosis in man.
    Boeijinga PH; Soufflet L; Santoro F; Luthringer R
    J Psychopharmacol; 2007 May; 21(3):321-37. PubMed ID: 17591659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine.
    Mouri A; Noda Y; Noda A; Nakamura T; Tokura T; Yura Y; Nitta A; Furukawa H; Nabeshima T
    Mol Pharmacol; 2007 Jun; 71(6):1598-609. PubMed ID: 17344353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Glutamatergic hypothesis of schizophrenia: psychoses induced by phencyclidine and cortical-subcortical imbalance].
    Krebs MO
    Encephale; 1995; 21(5):581-8. PubMed ID: 8529568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects.
    Krystal JH; Abi-Saab W; Perry E; D'Souza DC; Liu N; Gueorguieva R; McDougall L; Hunsberger T; Belger A; Levine L; Breier A
    Psychopharmacology (Berl); 2005 Apr; 179(1):303-9. PubMed ID: 15309376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NMDA antagonist model for schizophrenia: promise and pitfalls.
    Abi-Saab WM; D'Souza DC; Moghaddam B; Krystal JH
    Pharmacopsychiatry; 1998 Jul; 31 Suppl 2():104-9. PubMed ID: 9754841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The acute effects of NMDA antagonism: from the rodent to the human brain.
    Gunduz-Bruce H
    Brain Res Rev; 2009 May; 60(2):279-86. PubMed ID: 18703087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactive effects of subanesthetic ketamine and haloperidol in healthy humans.
    Krystal JH; D'Souza DC; Karper LP; Bennett A; Abi-Dargham A; Abi-Saab D; Cassello K; Bowers MB; Vegso S; Heninger GR; Charney DS
    Psychopharmacology (Berl); 1999 Jul; 145(2):193-204. PubMed ID: 10463321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-methyl d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex.
    Pinault D
    Biol Psychiatry; 2008 Apr; 63(8):730-5. PubMed ID: 18022604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study.
    Deakin JF; Lees J; McKie S; Hallak JE; Williams SR; Dursun SM
    Arch Gen Psychiatry; 2008 Feb; 65(2):154-64. PubMed ID: 18250253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of low dose ketamine effects by naltrexone: potential implications for the pharmacotherapy of alcoholism.
    Krystal JH; Madonick S; Perry E; Gueorguieva R; Brush L; Wray Y; Belger A; D'Souza DC
    Neuropsychopharmacology; 2006 Aug; 31(8):1793-800. PubMed ID: 16395307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does ketamine mimic aspects of schizophrenic speech?
    Covington MA; Riedel WJ; Brown C; He C; Morris E; Weinstein S; Semple J; Brown J
    J Psychopharmacol; 2007 May; 21(3):338-46. PubMed ID: 17591660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.